Loading…
A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Awan, Farrukh T., Hillmen, Peter, Hellmann, Andrzej, Robak, Tadeusz, Hughes, Steven G., Trone, Denise, Shannon, Megan, Flinn, Ian W., Byrd, John C.
Published in British journal of haematology (01.11.2014)
Published in British journal of haematology (01.11.2014)
Get full text
Journal Article
Loading…
Loading…
Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
Askanase, Anca, Byron, Margie, Keyes-Elstein, Lynette, Cagnoli, Patricia, McCune, W. Joseph, Chatham, W. Winn, Contreras, Gabriel, Daikh, David, Dall'Era, Maria, Wofsy, David, Davidson, Anne, Diamond, Betty, Mackay, Meggan, Ding, Linna, Gao, Wendy, Dooley, Mary Anne, Fragoso-Loyo, Hilda, Sanchez-Guerrero, Jorge, Karp, David, Olsen, Nancy, Jolly, Meenakshi, Kalunian, Kenneth, Kamen, Diane, Lee, Iris, Levesque, Marc C., Lim, S. Sam, Ramos-Remus, Cesar, Rovin, Brad, Sayre, Peter, Smilek, Dawn, Tosta, Patti, Utset, Tammy, Venuturupalli, Swamy, Winchester, Robert
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.11.2014)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.11.2014)
Get full text
Journal Article
Loading…
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis
Palladini, Giovanni, Sachchithanantham, Sajitha, Milani, Paolo, Gillmore, Julian, Foli, Andrea, Lachmann, Helen, Basset, Marco, Hawkins, Philip, Merlini, Giampaolo, Wechalekar, Ashutosh D.
Published in Blood (30.07.2015)
Published in Blood (30.07.2015)
Get full text
Journal Article
Loading…
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Walter, Steffen, Weinschenk, Toni, Stenzl, Arnulf, Zdrojowy, Romuald, Pluzanska, Anna, Szczylik, Cezary, Staehler, Michael, Brugger, Wolfram, Dietrich, Pierre-Yves, Mendrzyk, Regina, Hilf, Norbert, Schoor, Oliver, Fritsche, Jens, Mahr, Andrea, Maurer, Dominik, Vass, Verona, Trautwein, Claudia, Lewandrowski, Peter, Flohr, Christian, Pohla, Heike, Stanczak, Janusz J, Bronte, Vincenzo, Mandruzzato, Susanna, Biedermann, Tilo, Pawelec, Graham, Derhovanessian, Evelyna, Yamagishi, Hisakazu, Miki, Tsuneharu, Hongo, Fumiya, Takaha, Natsuki, Hirakawa, Kosei, Tanaka, Hiroaki, Stevanovic, Stefan, Frisch, Jürgen, Mayer-Mokler, Andrea, Kirner, Alexandra, Rammensee, Hans-Georg, Reinhardt, Carsten, Singh-Jasuja, Harpreet
Published in Nature medicine (01.08.2012)
Published in Nature medicine (01.08.2012)
Get full text
Journal Article
Loading…
Vitalize Trial: A Phase 2b, Open-Label, Multicenter, Randomized Parallel-Group, Two-Stage, Study of the Novel Immunotherapeutic, Maveropepimut-S, and Pembrolizumab with and without Intermittent Low-Dose Cyclophosphamide, in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Matasar, Matthew J., Lee, Eric, Leitch, Sophie, Solh, Melhem, Teti, Jennifer, Mody, Kabir, Fiset, Stephan, Graff, Jeremy
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Loading…
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients
Helsby, Nuala, Yong, Minghan, Burns, Kathryn, Findlay, Michael, Porter, David
Published in Cancer chemotherapy and pharmacology (01.09.2021)
Published in Cancer chemotherapy and pharmacology (01.09.2021)
Get full text
Journal Article
Loading…
Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer
Mulligan, Jude M., Hill, Laura A., Deharo, Steve, Irwin, Gareth, Boyle, David, Keating, Katherine E., Raji, Olaide Y., McDyer, Fionnuala A., O’Brien, Eamonn, Bylesjo, Max, Quinn, Jennifer E., Lindor, Noralane M., Mullan, Paul B., James, Colin R., Walker, Steven M., Kerr, Peter, James, Jacqueline, Davison, Timothy S., Proutski, Vitali, Salto-Tellez, Manuel, Johnston, Patrick G., Couch, Fergus J., Paul Harkin, D., Kennedy, Richard D.
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Get full text
Journal Article
Loading…
Loading…
Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study
Goldin, Jonathan, Elashoff, Robert, Kim, Hyun J, Yan, Xaiohong, Lynch, David, Strollo, Diane, Roth, Michael D, Clements, Philip, Furst, Daniel E, Khanna, Dinesh, Vasunilashorn, Srainnapha, Li, Gang, Tashkin, Donald P
Published in Chest (01.11.2009)
Published in Chest (01.11.2009)
Get more information
Journal Article
Loading…
Long-Term Evaluation of Efficacy and Safety of Ofatumumab Added to Fludarabine & Cyclophosphamide in Subjects with Relapsed Chronic Lymphocytic Leukemia: Final Analysis of Complement 2 Trial
Grosicki, Sebastian, Lech-Maranda, Ewa, Govind Babu, K, Rybka, Justyna, Litvinskaya, Elena, Loscertales, Javier, Kryachok, Irina, Kłoczko, Janusz, Rekhtman, Grygoriy, Homenda, Wojciech, Blonski, Jerzy, Stefanelli, Tommaso, Vincent, Ghislaine, Banerjee, Hiya, Robak, Tadeusz
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Loading…
87PNew clinical data from the DeCidE1 trial: Results on DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with advanced recurrent epithelial ovarian cancer
Dorigo, O, Oza, A M, Tanyi, J L, Strauss, J, Pejovic, T, Ghamande, S, Ghatage, P, Villella, J, Fiset, S, MacDonald, L D, Torrey, H, Weir, G M, Hrytsenko, O, Stanford, M M, Newton, R, Leopold, L, Rosu, G N
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Loading…
New clinical data from the DeCidE1 trial: Results on DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with advanced recurrent epithelial ovarian cancer
Dorigo, O., Oza, A.M., Tanyi, J.L., Strauss, J., Pejovic, T., Ghamande, S., Ghatage, P., Villella, J., Fiset, S., MacDonald, L.D., Torrey, H., Weir, G.M., Hrytsenko, O., Stanford, M.M., Newton, R., Leopold, L., Rosu, G.N.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Loading…
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
Cohen, Adam D., Garfall, Alfred L., Stadtmauer, Edward A., Melenhorst, J. Joseph, Lacey, Simon F., Lancaster, Eric, Vogl, Dan T., Weiss, Brendan M., Dengel, Karen, Nelson, Annemarie, Plesa, Gabriela, Chen, Fang, Davis, Megan M., Hwang, Wei-Ting, Young, Regina M., Brogdon, Jennifer L., Isaacs, Randi, Pruteanu-Malinici, Iulian, Siegel, Don L., Levine, Bruce L., June, Carl H., Milone, Michael C.
Published in The Journal of clinical investigation (01.06.2019)
Published in The Journal of clinical investigation (01.06.2019)
Get full text
Journal Article
Loading…
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
Pedraza, Alexandra, Salas, María Queralt, Rodríguez-Lobato, Luis Gerardo, Charry, Paola, Suárez-Lledo, María, Martínez-Cibrian, Nuria, Doménech, Ariadna, Solano, Maria Teresa, Arcarons, Jordi, de Llobet, Noemí, Rosiñol, Laura, Gutiérrez-García, Gonzalo, Avilés, Francesc Fernández, Urbano-Ispízua, Álvaro, Rovira, Montserrat, Martínez, Carmen
Published in Transplantation and cellular therapy (01.03.2023)
Published in Transplantation and cellular therapy (01.03.2023)
Get full text
Journal Article
Loading…
1208P - Safety and efficacy results of the combination of DPX-Survivac, pembrolizumab and intermittent low dose cyclophosphamide (CPA) in subjects with advanced and metastatic solid tumours: Preliminary results from the hepatocellular carcinoma (HCC), NSCLC, bladder cancer, & MSI-H cohorts
Conter, H.J., MacDonald, L.D., Fiset, S., Bramhecha, Y.M., Chaney, M., Rosu, G.N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Loading…
1208PSafety and efficacy results of the combination of DPX-Survivac, pembrolizumab and intermittent low dose cyclophosphamide (CPA) in subjects with advanced and metastatic solid tumours: Preliminary results from the hepatocellular carcinoma (HCC), NSCLC, bladder cancer, & MSI-H cohorts
Conter, H J, MacDonald, L D, Fiset, S, Bramhecha, Y M, Chaney, M, Rosu, G N
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Loading…
Bioanalysis of samples from advanced ovarian cancer subjects treated with a combination of DPX-Survivac, metronomic cyclophosphamide, and epacadostat: Preliminary data from the phase Ib DeCidE 1 Trial
Hrytsenko, Olga, Weir, Genevieve, Tram, Cynthia, Torrey, Heather, Newton, Robert Charles, Stanford, Marianne
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Loading…
Safety and efficacy results of the combination of DPX-Survivac, pembrolizumab and intermittent low dose cyclophosphamide (CPA) in subjects with advanced and metastatic solid tumours: Preliminary results from the hepatocellular carcinoma (HCC), NSCLC, bladder cancer, & MSI-H cohorts
Conter, H.J., MacDonald, L.D., Fiset, S., Bramhecha, Y.M., Chaney, M., Rosu, G.N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Loading…
DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE 1 trial): T cell responses and tumor infiltration correlate with tumor regression
Tanyi, Janos Laszlo, Dorigo, Oliver, Oza, Amit M., Strauss, James Fredric, Pejovic, Tanja, Ghamande, Sharad A., Ghatage, Prafull, Villella, Jeannine A., Fiset, Stephan, MacDonald, Lisa Diana, Hrytsenko, Olga, Stanford, Marianne, Newton, Robert C, Leopold, Lance, Rosu, Gabriela Nicola
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article